AstraZeneca and its roxadustat partner FibroGen headed into a high-stakes FDA expert meeting this week after receiving tough safety questions about the med from agency staffers. The daylong event Thursday featured bruising feedback, and their application now faces even more uncertainty. In a 13 to 1 vote, FDA committee panelists said that the drug should not be approved… Read More »
Breadcrumb Trail Links News Health Canada It’s time to halt AstraZeneca shots in Canada, except for people 40 or older in hotspots, says Andrew Morris, a doctor on Ontario’s COVID-19 science advisory table Author of the article: Sharon Kirkey Publishing date: May 11, 2021 • 1 hour ago • 6 minute read • 322 Comments Empty… Read More »
Concern over blood clots in a small number of patients who have received the Oxford/AstraZeneca vaccine have led to a number of countries suspending its use. But out of 20 million people who were vaccinated against coronavirus by the end of March in the UK, only 79 people had blood clots, and 19 people died.… Read More »
Breadcrumb Trail Links News Health Canada ‘The more transparent they are about communicating what is known about possible risks the more that could undermine trust in vaccination’ Author of the article: Sharon Kirkey Publishing date: Mar 31, 2021 • 1 day ago • 5 minute read • 108 Comments The latest controversy over AstraZeneca “presents an… Read More »